Capecitabine (Cap) combined with bevacizumab (Bev) with or without vinorelbine (Vin) in first-line metastatic breast cancer (MBC): First safety results from the randomized CARIN trial. 1. Juni 2011 Hegewisch-Becker, S., Lerchenmüller, C.A., Welt, A., Decker, T., Just, M., Steffens, C., Hipper, A., Marschner, N., 2011. J Clin Oncol (Meeting Abstracts). 2011;29(suppl; abstract 1044). doi: 10.1200/jco.2011.29.15_suppl.1044 Abstract Treatment of patients with Multiple Myeloma Routine treatment by office-based haematologists in Germany – Data from the Tumour Registry Lymphatic Neoplasms. Hartmann, H., Knauf, W., Abenhardt, W., Aldaoud, A., Lerchenmüller, C., Koska, M., 2011. ISPOR 14th Annual European Congress. Cancer: Clinical Outcomes Studies. Weiterlesen Biomarker response on exposure to sunitinib and its primary metabolite (SU12662) in metastatic colorectal cancer patients. Kanefendt, F., Lindauer, A., Kinzig, M., Strumberg, D., Scheulen, M.E., Mross, K., Fischer, R., Moritz, B., Sörgel, F., Jaehde, U., 2011. Int J Clin Pharmacol… Weiterlesen